メニュー

  1. 国立循環器病研究センター 病院 TOP
  2. 診療科・部門のご案内
  3. 脳血管部門 - 脳血管内科・脳神経内科
  4. さらに詳しく - 脳血管内科（脳内Aグループ）　2010年　論文業績

脳血管内科・脳神経内科

さらに詳しく
脳血管内科（脳内Aグループ）　2010年　論文業績

脳血管内科（脳内Aグループ）　2010年　論文業績

【原著】

  1. Hirano T, Sasaki M, Mori E, Minematsu K, Nakagawara J, Yamaguchi T, for the Japan Alteplase Clinical Trial II Group： Residual vessel length on magnetic resonance angiography identifies poor responders to alteplase in acute middle cerebral artery occlusion patients. Exploratory analysis of the Japan Alteplase Clinical Trial II. Stroke, 41： 2828-2833, 2010.
  2. Kuwashiro T, Toyoda K, Yoshimura S, Koga M, Naganuma M, Otsubo R, Konaka K, Uehara T, Naritomi H, Minematsu K： Atheromatous plaques at the origin of the left subclavian artery in patients with ischemic stroke. Cerebrovasc Dis, 29： 290-296, 2010.
  3. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, Minematsu K： Enlargement of acute intracerebral hematomas in patients on long-term warfarin treatment. Cerebrovasc Dis, 29： 446-453, 2010.
  4. Matsumoto S, Takada T, Yasaka M, Kasuya J, Yamada K, Naritomi H, Minematsu K： Intracranial arterial dissections in ischemic stroke assessed by 3D rotational angiography. J Neurol Sci, 296： 55-58, 2010.
  5. Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Sasaki M, Hirano T, for the J-ACT II Group： Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion japan alteplase clinical trial II (J-ACT II). Stroke, 41： 461-465, 2010.
  6. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcomes after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study. Cerebrovasc Dis, 31:123-129, 2010.
  7. Nakagawara J, Minematsu K, Okada Y, Tanahashi N, Nagahiro S, Mori E, Shinohara Y, Yamaguchi T, for J-MARS investigators： Thrombolysis with 0.6mg/kg intravenous alteplase for acute ischemic stroke in routine clinical practice the japan post-marketing alteplase registration study (J-MARS). Stroke, 41： 1984-1989, 2010.
  8. Nakajima M, Hirano T, Naritomi H, Minematsu K： Symptom progression or fluctuation in transient ischemic attack patients predicts subsequent stroke. Cerebrovasc Dis, 29： 221-227, 2010.
  9. Nakajima M, Takada T, Terasaki Y, Nagano K, Naritomi H, Minematsu K： Clinical significance of oral intake in patients with acute stroke. Dysphagia, 25： 192-197, 2010.
  10. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Naganuma M, Minematsu K, Toyoda K： Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA SAMURAI rt-PA Registry. Neurology, 75： 555-561, 2010.
  11. Sato S, Toyoda K, Matsuoka H, Okatsu H, Kasuya J, Takada T, Shimode A, Uehara T, Naritomi H, Minematsu K： Isolated anterior cerebral artery territory infarction： dissection as an etiological mechanism. Cerebrovasc Dis, 29： 170-177, 2010.
  12. Shono Y, Koga M, Toyoda K, Matsuoka H, Yokota C, Uehara T, Yamamoto H, Minematsu K： Medial medullary infarction identified by diffusion -weighted magnetic resonance imaging. Cerebrovasc Dis, 30： 519-524, 2010.
  13. Thompson BB, Bejot Y, Caso V, Castillo J, Christensen H, Flaherty ML, Foerch C, Ghandehari K, Giroud M, Greenberg SM, Hallevi H, Hemphill JC III, Heuschmann P, Juvela S, Kimura K, Myint PK, Nagakane Y, Naritomi H, Passero S, Rodriguez-Yanez MR, Roquer J, Rosand J, Rost NS, Saloheimo P, Salomaa V, Sivenius J, Sorimachi T, Togha M, Toyoda K, Turaj W, Vemmos KN, Wolfe CDA, Woo D, Smith EE： Prior antiplatelet therapy and outcome following intracerebral hemorrhage a systematic review. Neurology, 75：1333-1342, 2010.
  14. Toyoda K, Yasaka M, Uchiyama S, Nagao T, Gotoh J, Nagata K, Koretsune Y, Sakamoto T, Iwade K, Yamamoto M, Takahashi J C, Minematsu K, on behalf of the bleeding with antithrombotic therapy (BAT) study group： Blood pressure levels and bleeding events during antithrombotic therapy the bleeding with antithrombotic therapy (BAT) study. Stroke, 41： 1440-1444, 2010.
  15. Yoshimura S, Toyoda K, Kuwashiro T, Koga M, Otsubo R, Konaka K, Naganuma M, Matsuoka H, Naritomi H, Minematsu K： Ulcerated plaques in the aortic arch contribute to symptomatic multiple brain infarction. J Neurol Neurosurg Psychatry, 81： 1306-1311, 2010.
  16. Hirata K, Kuge Y, Yokota C, Harada A, Kokame K, Inoue H, Kawashima H, Hanzawa H, Shono Y, Saji H, Minematsu K, Tamaki N: Gene and protein analysis of brain derived neurotrophic factor expression in relation to neurological recovery induced by an enriched environment in a rat stroke model. Neurosci Lett. 495: 210-215, 2011
  17. Kawano H, Yamamoto H, Miyata S, et al: Prospective multicenter cohort study of heparin-induced thrombocytopenia in acute ischemic stroke patients. Br J Haematol 2011, in press
  18. Koga M, Kimura K, Shibazaki K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Naganuma M, Nezu T, Maeda K, Minematsu K, Toyoda K: CHADS(2) score is associated with 3-month clinical outcomes after intravenous rt-PA therapy in stroke patients with atrial fibrillation: SAMURAI rt-PA Registry. J Neurol Sci. 306: 49-53, 2011
  19. Koga M, Toyoda K, Nakashima T, Hyun B, Uehara T, Yokota C, Nagatsuka K, Naritomi H, Minematsu K: Carotid duplex ultrasonography can predict outcome of intravenous alteplase therapy for hyperacute stroke. J Stroke Cerebrovasc Dis, 20: 24-29, 2011.
  20. Koga M, Uehara T, Yasui N, Hasegawa Y, Nagatsuka K, Okada Y, Minematsu K. Influencing factors of cooperation among healthcare providers in a community-based stroke care system in Japan. J Stroke and Cerebrovasc Dis, 2010, Epub ahead of print.
  21. Kuwashiro T, Toyoda K, Oyama N, Kawase K, Okazaki S, Nagano K, Koga M, Matsuo H, Naritomi H, Minematsu K. High plasma D-Dimer is a marker of deep vein thrombosis in acute stroke. J Stroke Cerebrovasc Dis. 2010, Epub ahead of print.
  22. Kuwashiro T, Yasaka M, Itabashi R, Nakagaki H, Miyashita F, Naritomi H, Minematsu K: Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage. Cerebrovasc Dis, 31: 170-176, 2011.
  23. Mori E, Minematsu K, Nakagawara J, Yamaguchi T, for the Japan Alteplase Clinical Trial (J-ACT) Group： Factors predicting outcome in acute ischemic stroke patients treated with 0.6 mg/kg alteplase： Evidence from the Japan Alteplase Clinical Trial (J-ACT). J Stroke Cerbrovasc Dis, Epub ahead of print.
  24. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcom after intravenous rt-PA： the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis, 31: 123-129, 2011.
  25. Naganuma M, Mori M, Nezu T, Makihara N, Koga M, Okada Y, Minematsu K, Toyoda K on behalf of the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators: Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) rt-PA Registry. Eur Neurol 2011, in press
  26. Nagasawa　H, Yokota C, Toyoda K, Ito A, Minematsu K, : High level of plasma adiponectin in acute stroke patients is associated with stroke mortality. J Neuro Sci, 304:102-106, 2011.
  27. Nezu T, Koga M, Nakagawara J, Shiokawa Y, Yamagami H, Furui E, Kimura K, Hasegawa Y, Okada Y, Okuda S, Kario K, Naganuma M, Maeda K, Minematsu K, Toyoda K: Early ischemic change on CT versus DWI for stroke patients receiving intravenous rt-PA therapy: SAMURAI rt-PA Registry. Stroke 2011, in press
  28. Tomii Y, Matsuoka H, Torii T, Uehara T, Toyoda K, Minematsu K： A new ultrasound method for evaluating dysphasia in acute stroke patients. Int J Stroke, 6:279-280, 2011
  29. Shono Y, Yokota C, Kuge Y, Kido S, Harada A, Kokame K, Inoue H, Hotta M, 　　Hirata K, Saji H, Tamaki N, Menematsu K: Gene expression associated　with an enriched environment after transient focal ischemia. Brain research 1376: 60-65, 2011.
  30. Yakushiji Y, Yokota C, Yamada N, Kuroda Y, Minematsu K： Clinical characteristics by topographical distribution of brain microbleeds, with a particular emphasis on diffuse microbleeds. J Stroke Cerebrovasc Dis, 20:214-221, 2011.

【症例報告】

  1. Nakajima M, Ohtsuki T, Minematsu K： Bilateral hypogeusia in a patient with a unilateral paramedian thalamic infarction. J Neurol Neurosurg Psychiatry, 81： 700-701, 2010.
  2. Nezu T, Naganuma M, Shono Y, Toyoda K, Minematsu K： Central apnoea associated with subcortical haemorrhage in the left temporal lobe. J Neurol Neurosurg Psychiatry, 81：299-30, 2010.
  3. Mori M, Yamamoto H, Koga M, Okatsu H, Shono Y, Toyoda K, Fukuda K, Iihara K, Yamada N, Minematsu K: Hyoid bone compression induced repetitive occlusion and recanalization of the internal carotid artery in a patient with ipsilateral brain and retinal ischemia. Arch Neurol, 68:258-259, 2011.

【英文その他】

  1. Toyoda K, Koga M, Minematsu K, on behalf of the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study investigators： Response to letter by Loh and sharma. Stroke, 41： 165, 2010.
  2. Hennerici MG, Minematsu K, Leys D, Toyoda K, Uchiyama S, Diener H-C: Journal Anniversary Symposium 2010 dedicated to Europe/Japan stroke research cooperation. Cerebrovasc Dis 30:537-539, 2010

最終更新日：2021年10月08日

設定メニュー